Skip to content

Evaluation of a Medical Food for Chronic Wounds

Evaluation of a Medical Food for Chronic Wounds

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00711217
Enrollment
271
Registered
2008-07-08
Start date
2008-06-30
Completion date
2010-12-31
Last updated
2011-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foot Ulcer, Diabetic

Brief summary

The study objective is to compare outcomes in subjects with a diabetic foot ulcer after 16 weeks of consuming a medical food versus a calorically similar control drink.

Interventions

twice daily

OTHERDrink mix calorically similar to experimental product

twice daily

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* non-pregnant * diabetic * neuropathic foot ulcer * ABI\> 0.7

Exclusion criteria

* uncontrolled DM * collagen vascular disease or autoimmune disease * wound infection; recent therapies with steroids * growth factor or bioengineered tissue * radiation therapy * treatment with antibiotics within 1 week, Charcot's arthropathy of the foot * active malignancy * renal function impairment * liver failure * planned surgery * myocardial infarction within 3 months * malnutrition * substance abuse * taking conflicting oral nutritional supplements

Design outcomes

Primary

MeasureTime frame
Wound healing16 weeks

Secondary

MeasureTime frame
QOL16 weeks
Wound healing measures16 weeks
Incidence of complications16 weeks
Clinical outcome data16 weeks

Countries

Spain, Taiwan, United Kingdom, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026